Last week, I wrote a post about an article published by McKinsey & Company in which they interviewed 20 pharma executives about how they’re handling digital transformation. The article was jam-packed with great information, so I wanted to highlight a few more points for you.
In culling through the interviews, the authors identified these three critical themes:
- Dramatic changes in the traditional roles and dynamics of healthcare stakeholders have fundamental implications for pharma companies.
- It is time to reimagine them as solutions companies, not asset companies.
- The technology is ready, but pharma companies must change if they are going to enable and harness it more successfully.
They go on to say:
“These themes strongly suggest that success in the new digital environment will require three big shifts: forging ahead beyond the pack mentality and embracing experimentation and risk taking, developing a collaborative culture and challenging barriers to sharing, and reinventing companies by building capabilities beyond traditional healthcare and updating the operating model.”
For 30 real-life examples of how your peers are doing exactly that, download Perficient’s guide Life Sciences is Going Digital.
